Endo International PLC disclosed it is officially closing its women’s health division and stopping the manufacture and sale of transvaginal mesh products. Endo disclosed this after release of its quarterly results on Monday, stating that it will close down the mesh line purchased from American Medical Systems (AMS) by March 31, 2016. Endo failed to find… Read More
The Federal Drug Administration (FDA) has labeled Pelvic Organ Prolapse (POP) devices as “high risk”, after thousands of injuries had been reported. The FDA noted more than 4,000 reports of adverse events or complications associated with transvaginal surgical mesh for POP or Stress Urinary Incontinence (SUI) repair from 2005 to 2010. The FDA previously classified POP… Read More
On June 11, 2015, Rachel Abrams, and others from Levin Simes Abrams attended the 2015 Equal Rights Advocates Gala Luncheon—Forging Ahead—where we celebrated ERA’s 41 years of groundbreaking work making sure girls and boys feel safe at school so they can learn effectively, advocating in favor of equal pay for equal work, and taking on… Read More
After being sued by over 600 women who claim that their transvaginal mesh products caused serious-life altering injuries, Johnson & Johnson’s Ethicon unit has decided to stop selling four of its most popular transvaginal mesh products and restrict the usage of other Gynecare mesh products. In a letter filed on June 04, 2012 with U.S.… Read More
